GURU.Markets stock price, segment price, and overall market index valuation
The company's share price ATNF
Shares of 180 Life Sciences, a biotech focused on treating inflammatory diseases, reflect its efforts to commercialize its developments. Their price trajectory is volatile and dependent on news about clinical trials.
Share prices of companies in the market segment - Crypto
180 Life Sciences is a biopharmaceutical company developing drugs for the treatment of inflammatory diseases, particularly early-stage ones. We've classified it under "Crypto" (likely a miscategorization), although its focus is immunology. The chart below shows the dynamics of the biotech sector.
Broad Market Index - GURU.Markets
180 Life Sciences is a biopharmaceutical company developing drugs to treat inflammatory diseases. As a component of the GURU.Markets index, it represents the biotech sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
ATNF - Daily change in the company's share price ATNF
For ETHZilla Corporation, a cryptocurrency company, daily volatility is a direct measure of digital asset price sensitivity. This metric reflects market conditions and investor sentiment in this high-risk niche.
Daily change in the price of a set of shares in a market segment - Crypto
180 Life Sciences (ATNF) is a biopharmaceutical company developing drugs to treat inflammatory diseases. This segment of the biotech industry is extremely sensitive to clinical trial results. The chart below illustrates the high volatility typical of this sector.
Daily change in the price of a broad market stock, index - GURU.Markets
ETHZilla is a company operating in the cryptocurrency and blockchain space. Its shares directly reflect the extreme volatility of the digital asset market. The movements of such companies act as a bridge through which "crypto storms" are carried into the stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization ATNF
The year-over-year performance of ETHZilla Corporation, formerly known as 180 Life Sciences, reflects its strategic pivot toward cryptocurrency and blockchain technologies. Its 12-month market cap change is an indicator of investor confidence in the new team and its ability to create value in this volatile and rapidly evolving market.
Annual dynamics of market capitalization of the market segment - Crypto
180 Life Sciences, a biotech company, focuses on treating inflammatory diseases. Its performance is completely independent of the sector and depends on news about clinical trials. Its stock price will reflect investors' speculative belief in the potential of its unique scientific developments.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
ETHZilla Corporation (formerly 180 Life Sciences), a cryptocurrency company, exhibits the dynamics typical of highly speculative assets. Its annual market capitalization, compared to the market, reflects crypto market sentiment rather than fundamentals, leading to extreme volatility and a disconnect from overall economic trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization ATNF
ETHZilla, as its name suggests, is associated with cryptocurrencies. The value of such companies is extremely volatile. Their monthly fluctuations directly reflect crypto market sentiment, the price of Ethereum, and news about partnerships and technological developments.
Monthly dynamics of market capitalization of the market segment - Crypto
ETHZilla Corporation (formerly 180 Life Sciences) now appears to be focusing on cryptocurrencies. This sector is one of the most volatile and speculative. The chart below will reflect the extreme price fluctuations of digital assets that determine the fate of companies operating in this unpredictable industry.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
180 Life Sciences (ticker: ATNF) is a biotech company focused on inflammatory diseases. Its stock price is driven not by the market, but by progress in clinical trials. This is a high-risk bet on the success of scientific developments in one of the most complex areas of medicine.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization ATNF
The weekly performance of ETHZilla Corporation, a cryptocurrency company, reflects market sentiment. Its price is highly correlated with the prices of major cryptocurrencies and industry news. The chart below clearly demonstrates this high volatility and dependence on the crypto sector.
Weekly dynamics of market capitalization of the market segment - Crypto
ETHZilla Corporation (ATNF) is a company whose name suggests a connection to cryptocurrencies. Shares of such companies typically follow the prices of major cryptocurrencies, such as Ethereum, and are subject to extreme speculative fluctuations. The chart will show this close connection to the volatile crypto market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
ETHZilla Corporation operates in the highly volatile crypto sector. This chart clearly demonstrates how its weekly fluctuations are synchronized with the general hype and downturns in the crypto industry, and completely disconnected from the dynamics of the traditional stock market.
Market capitalization of the company, segment and market as a whole
ATNF - Market capitalization of the company ATNF
The ETHZilla Corporation (formerly 180 Life Sciences) valuation chart reflects its radical shift in direction. Its market cap, previously tied to biotech, now represents a speculative bet on its new, as yet unclear, plans in the cryptocurrency space. The dynamics illustrate the extreme level of risk and uncertainty.
ATNF - Share of the company's market capitalization ATNF within the market segment - Crypto
ETHZilla's (formerly 180 Life Sciences) share of the crypto sector likely reflects a radical shift from biotech to blockchain. Its market share is a highly speculative estimate of its new cryptocurrency initiatives, which represent a complete rebranding and business model shift.
Market capitalization of the market segment - Crypto
This chart shows the total market capitalization of small speculative companies. ETHZilla Corporation (formerly 180 Life Sciences) is an example of such a structure. The chart's dynamics reflect retail investor sentiment and changes in business strategy rather than fundamentals.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart visualizes the market valuation of a company operating in the cryptocurrency and biotechnology sectors. The market capitalization of ETHZilla Corporation (formerly 180 Life Sciences) reflects its diversified and risky projects. The line shows the roller coaster of speculative ideas competing for a share of the future economy.
Book value capitalization of the company, segment and market as a whole
ATNF - Book value capitalization of the company ATNF
ETHZilla Corporation's assets are its technology platform and digital asset portfolio. The chart below reflects the financial valuation of its software, blockchain solutions, and cryptocurrency investments, forming the basis for its activities in this industry.
ATNF - Share of the company's book capitalization ATNF within the market segment - Crypto
ETHZilla's tangible assets include its IT infrastructure and, possibly, cryptocurrency mining or staking equipment. The chart shows its stake in these physical, albeit digital, assets, which form the basis of its crypto operations.
Market segment balance sheet capitalization - Crypto
Against the backdrop of a capital-intensive financial sector, ETHZilla is building its empire in the digital space. Its business is blockchain technology. The chart shows the material resources ETHZilla has abandoned to become part of a new, "lightweight" financial infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
ETHZilla Corporation (formerly 180 Life Sciences) is a company operating in the cryptocurrency or biotechnology space. Its assets range from computing power and digital assets to scientific research and patents. The chart shows the material weight of its core activities within its innovation niche.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - ATNF
ETHZilla Corporation (formerly 180 Life Sciences) is a company whose operations and valuation are heavily dependent on its strategy in crypto assets and technology. This chart will show how the market reacts to crypto market volatility and the company's specific steps in this area. This is an assessment of potential, not tangible assets.
Market to book capitalization ratio in a market segment - Crypto
ETHZilla Corporation, formerly 180 Life Sciences, operates in the cryptocurrency and biotechnology sectors. Valuing such diversified companies is complex. This chart shows how the market values its portfolio of initiatives relative to their book value.
Market to book capitalization ratio for the market as a whole
ETHZilla Corporation (formerly 180 Life Sciences) is a company focused on cryptocurrency and blockchain. This chart reflects the market's speculative valuation of their business. The price action is highly dependent on overall sentiment and trends in the cryptocurrency market.
Debts of the company, segment and market as a whole
ATNF - Company debts ATNF
ETHZilla Corporation (formerly 180 Life Sciences) is a speculative company with an evolving focus. Its financial strategy relies entirely on raising capital through share placements to fund various ideas, whether biotechnology or cryptocurrency, which carries extremely high risk.
Market segment debts - Crypto
ETHZilla Corporation (ATNF), operating in the cryptocurrency industry, has an unconventional financial structure. This chart shows how its debt policy (or lack thereof) reflects the highly volatile and speculative nature of the crypto market, where funding often comes from unconventional sources.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio ATNF
Atrion Corporation produces niche medical and industrial products. The company is known for its conservative financial policies. This chart likely shows low debt levels, reflecting its organic growth strategy and focus on profitability rather than aggressive expansion.
Market segment debt to market segment book capitalization - Crypto
ETHZilla Corporation (formerly 180 Life Sciences) is likely a company operating in the cryptocurrency or blockchain space. This chart compares its debt load to the total market capitalization of the entire crypto sector. It helps understand how the company finances its technology projects in this volatile industry.
Debt to book value of all companies in the market
ETHZilla Corporation (ATNF) is a company involved in cryptocurrency and blockchain. This is a highly volatile and speculative field. This chart of overall debt trends, reflecting risk appetite in the traditional economy, only highlights how much riskier and more unpredictable project financing can be in the crypto space.
P/E of the company, segment and market as a whole
P/E - ATNF
This chart shows the valuation of ETHZilla Corporation (formerly 180 Life Sciences), a company with a mixed business focus. If it's focused on crypto, its valuation will be highly speculative and entirely dependent on the state of the digital asset market, making its P/E unpredictable.
P/E of the market segment - Crypto
ETHZilla Corporation, also known as 180 Life Sciences, is a biotech company focused on developing drugs to treat inflammatory diseases. This chart shows the average valuation for the crypto sector, reflecting how investors view the risks and potential of smaller biotech companies.
P/E of the market as a whole
ETHZilla Corporation (formerly 180 Life Sciences) is likely a cryptocurrency or biotech company, judging by its previous names. Frequent name and business changes indicate high risk. This chart, reflecting risk appetite, serves as a barometer of the market's attitude toward such speculative ventures.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company ATNF
ETHZilla Corporation is a holding company with a shifting focus, often related to cryptocurrencies and blockchain technologies. This chart reflects analysts' speculative expectations regarding the future profitability of its projects. Forecasts are highly volatile and depend on the state of the crypto market.
%20P%2FE%20ATNF&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-ATNF&v=1772530680734 "Chart of the company's future (projected) P/E ATNF")
Future (projected) P/E of the market segment - Crypto
ETHZilla Corporation (ATNF) is a company whose name and activities indicate speculative activity in the cryptocurrency or related space. This chart reflects extremely high risks. It compares the company's expectations, if any, to other microcap projects in the crypto industry.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Crypto&v=1772530680744 "Future (projected) P/E graph of the market segment - Crypto")
Future (projected) P/E of the market as a whole
ETHZilla Corporation (ATNF) is a company likely associated with cryptocurrencies or blockchain technologies. Success in this space depends heavily on investor risk appetite and overall interest in digital assets. This chart, which reflects sentiment in traditional markets, often correlates with capital flows into more speculative segments, such as crypto.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772530680757 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit ATNF
ETHZilla Corporation (formerly 180 Life Sciences) is a company operating in the cryptocurrency and biotechnology sectors. Its financial metrics reflect the current stage of its business model, whether development or commercialization. This chart shows the financial path of a company exploring or implementing its core strategy.
Profit of companies in the market segment - Crypto
ETHZilla Corporation, associated with 180 Life Sciences, likely operates in the cryptocurrency or biotech space. This chart, showing overall returns in the sector, reflects the high degree of risk and potential return. The company's future depends on its ability to create real value, whether a new drug or a successful crypto project, which will determine its impact on the industry.
Overall market profit
ETHZilla Corporation (formerly 180 Life Sciences) is a company involved in cryptocurrencies and possibly biotechnology. Its unclear focus and frequent name changes make its business model difficult to analyze and likely speculative.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company ATNF
ETHZilla Corporation (formerly 180 Life Sciences) is a cryptocurrency company. Future profit projections are highly speculative and depend on crypto market dynamics and the success of its blockchain-related projects.
%20profit%20of%20the%20company%20ATNF&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-ATNF&v=1772530680812 "Graph of future (projected) profit of the company ATNF")
Future (predicted) profit of companies in the market segment - Crypto
ETHZilla Corporation (formerly 180 Life Sciences) focuses on developing drugs to treat inflammatory diseases. This chart reflects profit forecasts for the entire crypto/pharma industry (based on current performance). It allows you to assess how the company's business compares to general expectations for its chosen volatile and risky industry.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Crypto&v=1772530680824 "Graph of future (predicted) profits of companies in a market segment - Crypto")
Future (predicted) profit of the market as a whole
ETHZilla Corporation (ATNF) operates in the cryptocurrency space. This sector is high-risk and highly dependent on investor sentiment. This chart, which reflects risk appetite in traditional markets, often correlates with the performance of crypto assets. During periods of optimism, capital flows more readily into speculative instruments, which benefits ATNF.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772530680868 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - ATNF
ETHZilla Corporation (formerly 180 Life Sciences) is a cryptocurrency company. This metric, which links market capitalization to revenue, reflects the highly speculative nature of its operations. It shows how investors value its projects in the volatile and rapidly changing crypto industry, where real revenue often takes a back seat.
P/S market segment - Crypto
ETHZilla Corporation, associated with 180 Life Sciences, is likely a holding company, possibly with interests in cryptocurrencies or biotechnology. This chart, reflecting the average valuation for the sector, allows investors to consider the company's actual business and how the market values its assets and potential revenue in light of its positioning.
P/S of the market as a whole
ETHZilla Corporation, formerly 180 Life Sciences, is a company whose name and focus may have changed, likely operating in speculative areas such as cryptocurrency or early-stage biotech. This chart, showing the average valuation, illustrates how disconnected the valuation of such companies can be from fundamentals.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company ATNF
ETHZilla Corporation (formerly 180 Life Sciences) operates in the cryptocurrency space. This chart shows the market's highly speculative estimate of future, hypothetical revenue. It reflects investors' belief in the cryptocurrency market's growth potential and the success of the company's specific projects.
%20P%2FS%20ATNF&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-ATNF&v=1772530680969 "The graph of the company's future (projected) P/S ATNF")
Future (projected) P/S of the market segment - Crypto
ETHZilla Corporation is a company involved in cryptocurrency and blockchain technologies. This chart reflects average expectations for future revenue in the crypto industry. It allows one to assess how the market views the company's business model and projects in this high-risk and rapidly changing sector compared to other publicly traded crypto companies.
%20P%2FS%20market%20segment%20graph%20-%20Crypto&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Crypto&v=1772530680986 "Future (projected) P/S market segment graph - Crypto")
Future (projected) P/S of the market as a whole
ETHZilla Corporation (ATNF), formerly 180 Life Sciences, is now focused on crypto. Their success isn't tied to the traditional economy reflected in this chart. It depends on blockchain innovations and the dynamics of crypto markets, which operate by their own, often unpredictable, rules.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772530681057 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales ATNF
This metric illustrates a company's activities in the cryptocurrency and blockchain space. Revenue can be generated through decentralized application development, platform fees, or investments in digital assets. Growth in this chart reflects the successful monetization of its products in the volatile but rapidly growing crypto industry.
Sales of companies in the market segment - Crypto
ETHZilla Corporation (formerly 180 Life Sciences) is a company that has shifted its focus to cryptocurrency-related technologies. Its revenue structure now likely reflects its activities in this new area, demonstrating its strategic pivot from biotechnology to digital assets.
Overall market sales
ETHZilla Corporation (formerly 180 Life Sciences) operates in the cryptocurrency and biotechnology sectors. This unusual combination makes it vulnerable to both the volatile digital asset market and advances in scientific research. This chart, reflecting overall economic sentiment, influences investor appetite for high-risk assets, whether biotech startups or cryptocurrencies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company ATNF
ETHZilla Corporation (formerly 180 Life Sciences) is a cryptocurrency company. Its revenue is dependent on the crypto market. This chart reflects analysts' speculative expectations regarding the future of digital assets and the company's business model.
%20sales%20of%20the%20company%20ATNF&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-ATNF&v=1772530681537 "Schedule of future (projected) sales of the company ATNF")
Future (projected) sales of companies in the market segment - Crypto
ETHZilla Corporation, formerly 180 Life Sciences, is involved in the cryptocurrency industry. This chart shows the outlook for the cryptocurrency sector. Its volatile dynamics, dependent on crypto asset prices and investor sentiment, directly determine the operating environment and potential revenue for companies in this space.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Crypto&v=1772530681655 "Schedule of future (projected) sales of companies in the market segment - Crypto")
Future (projected) sales of the market as a whole
This chart, reflecting investor appetite for risky assets, is important for ETHZilla Corporation. The cryptocurrency company relies on capital inflows into the sector. Positive macroeconomic forecasts and interest in new technologies are fueling growing interest in digital assets.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772530681714 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality ATNF
ETHZilla Corporation (ATNF), formerly 180 Life Sciences, is likely involved in cryptocurrency or biotech. If it's a crypto project, profitability will be volatile. If it's a biotech project, the chart reflects investment in research, and profitability is a long-term goal dependent on the success of clinical trials.
Market segment marginality - Crypto
ETHZilla Corporation appears to be a cryptocurrency and blockchain technology company, possibly with a focus on the Ethereum ecosystem. Profitability is highly dependent on crypto market volatility and the success of its projects. This chart shows returns in related technology sectors, providing context for assessing the risks and potential of its business model.
Market marginality as a whole
ETHZilla Corporation (formerly 180 Life Sciences) is a company operating in the cryptocurrency and biotechnology sectors. This combination makes it extremely sensitive to investor risk appetite. This chart, showing the overall state of the markets, is an indicator of whether investors are willing to invest in highly speculative and difficult to predict business models.
Employees in the company, segment and market as a whole
Number of employees in the company ATNF
ETHZilla Corporation (ATNF) is a company operating in the cryptocurrency space. This chart reflects the small team behind its projects. This small staff may indicate an early stage of development or a focus on technology development rather than large-scale operations, which is typical for many startups in this volatile industry.
Share of the company's employees ATNF within the market segment - Crypto
ETHZilla Corporation (formerly 180 Life Sciences) appears to have shifted its focus to cryptocurrencies, a common occurrence for small biotech companies. This chart may show a small stake in the crypto sector, reflecting the initial stages of its new strategy.
Number of employees in the market segment - Crypto
180 Life Sciences Corp. (ATNF) is a biopharmaceutical company developing drugs to treat inflammatory diseases. If the ticker symbol were associated with a crypto project, a crypto-related chart would be more relevant. For biopharma, the growing number of immunologist scientists indicates a high demand for new treatments for chronic inflammation.
Number of employees in the market as a whole
ETHZilla Corporation (formerly 180 Life Sciences), judging by its new ticker symbol, has shifted its focus to cryptocurrencies. This sector attracts capital when investors have available funds. This total employment chart reflects the health of the real economy. During periods of growth, people are more inclined to take on risky investments, which fuels the cryptocurrency market in which the company operates.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company ATNF (ATNF)
ETHZilla Corporation (ATNF) is a company focused on developing drugs to treat inflammatory diseases (formerly 180 Life Sciences). As a biotech, their value is determined by their "intellectual capital." This chart reflects their R&D pipeline, not their productivity in the traditional sense.
%20of%20the%20company%20ATNF%20(ATNF)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-ATNF-ATNF&v=1772530682228 "Chart of market capitalization per employee (in thousands of dollars) of the company ATNF (ATNF)")
Market capitalization per employee (in thousands of dollars) in the market segment - Crypto
ETHZilla Corporation (formerly 180 Life Sciences) is a cryptocurrency company based on digital assets and blockchain technology. The chart clearly demonstrates that in the crypto sector, market capitalization per employee can be extremely high, as value is created by code, not labor.
%20by%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Crypto&v=1772530682289 "Market capitalization per employee (in thousands of dollars) by market segment - Crypto")
Market capitalization per employee (in thousands of dollars) for the overall market
ETHZilla Corporation (ATNF), formerly 180 Life Sciences, is likely involved in cryptocurrency or biotechnology. If it's a crypto project, the high employee valuation will reflect the technology's value. If it's a biotech project, it will reflect the potential of scientific research. In both cases, valuation is not tied to a large staff, but to intellectual capital.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772530682343 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company ATNF (ATNF)
ETHZilla Corporation (ATNF, formerly 180 Life Sciences) is a chameleon company. Historically focused on R&D in anti-inflammatory drugs, it appears to be shifting its focus to cryptocurrency and blockchain. This chart likely shows the company's persistent loss-making costs: how much money it spends on each employee in pursuit of a new business model.
%20Chart%20ATNF%20(ATNF)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-ATNF-ATNF&v=1772530682390 "Company Profit Per Employee (in thousands of dollars) Chart ATNF (ATNF)")
Profit per employee (in thousands of dollars) in the market segment - Crypto
ETHZilla Corporation (ATNF) is a cryptocurrency company. This chart reflects its ability to generate profits in a highly volatile industry. High earnings per employee can be the result of successful investments in digital assets, blockchain technology development, or services in this space, but it comes with high risks.
%20in%20the%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Crypto&v=1772530682431 "Chart of profit per employee (in thousands of dollars) in the market segment - Crypto")
Profit per employee (in thousands of dollars) for the market as a whole
ETHZilla Corporation (ATNF) (formerly 180 Life Sciences) is a biotech company, but the ticker symbol ATNF is now associated with crypto projects. If it's 180 Life Sciences (R&D), the indicator is negative. If it's a new crypto project, it's impossible to assess its operational performance; it's speculative IT.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772530682537 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee ATNF (ATNF)
ETHZilla Corporation (formerly 180 Life Sciences) now appears to be immersed in cryptocurrency. This chart will reflect their progress in this new, volatile field. Revenue per employee dynamics will be highly dependent on the state of the crypto market and the effectiveness of their business model.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-ATNF-ATNF&v=1772530682679 "Sales chart per company employee ATNF (ATNF)")
Sales per employee in the market segment - Crypto
180 Life Sciences (ATNF) is a biotech R&D company focused on treating inflammatory diseases. It is a clinical-stage R&D company. This chart clearly shows that the company has no commercial revenue. The productivity of its research team is measured solely by progress in clinical trials.
Sales per employee for the market as a whole
Gorman-Rupp (GRC) is a manufacturer of pumps and pumping systems for critical applications, from municipal wastewater treatment to industry and construction. It is a niche industrial manufacturer. This chart reflects the efficiency of complex equipment production. Gorman-Rupp pumps are not consumer products, but durable equipment. The growth of this indicator speaks to the strength of the brand and the capabilities of the company's factories.
Short shares by company, segment and market as a whole
Shares shorted by company ATNF (ATNF)
ETHZilla (ATNF), formerly 180 Life Sciences, is a company that has abruptly shifted its focus to cryptocurrencies. This chart tracks bearish bets. The shorts reflect the view that it is a speculative shell, trying to profit from hype without having any real business.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-ATNF-ATNF&v=1772530682975 "Short Shares Chart for the Company ATNF (ATNF)")
Shares shorted by market segment - Crypto
ETHZilla (ATNF) (formerly 180 Life Sciences) is a biotech company developing drugs for inflammatory diseases. The chart below represents a general short position in the biotech sector. It demonstrates the general investor skepticism regarding the success of risky clinical trials.
Shares shorted by the overall market
ETHZilla (ATNF) is linked to cryptocurrencies, the most speculative asset class. When this indicator of *general* market pessimism rises, investors don't just "flee risk"—they flee it in panic. Crypto-related stocks like ATNF fall first, faster, and more severely than the rest of the market.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator ATNF (ATNF)
This oscillator for ETHZilla (180 Life Sciences) is a purely speculative barometer. The company has changed its focus (from biotech) and is now associated with crypto hype. "Overheating" (above 70) occurs during any bullish rally in crypto. The lack of real business and transparency keeps the stock "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-ATNF-ATNF&v=1772530683038 "RSI 14 indicator chart for the company's stock ATNF (ATNF)")
RSI 14 Market Segment - Crypto
ETHZilla (ATNF) operates in the crypto space. The RSI_14_Seg index for "Crypto" is a clear indicator of "hype" or "fear" in the industry. It's crucial to understand whether the interest in ATNF is their project or simply the overall crypto market being overheated.
RSI 14 for the overall market
ETHZilla (ATNF), a "crypto" company. Its business is pure risk appetite, as reflected in this chart. During periods of market euphoria, investors are willing to invest in the most speculative assets, pushing up both ATNF shares and the price of Bitcoin. During moments of panic, the opposite occurs: risk aversion collapses both.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ATNF (ATNF)
ETHZilla Corporation (ATNF) is a holding company focused on cryptocurrency and blockchain technologies. This chart shows the average 12-month analyst forecast. Their target price (if any) is highly speculative, depending entirely on crypto market volatility and their R&D.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ATNF-ATNF&v=1772530683114 "A chart showing analyst consensus forecasts for the expected stock price. ATNF (ATNF)")
The difference between the consensus estimate and the actual stock price ATNF (ATNF)
180 Life Sciences (ATNF) is a biotech company developing drugs to treat inflammatory diseases. This chart shows the difference between the market valuation and the consensus estimate. For an R&D company, this gap reflects analysts' faith (or skepticism) in their scientific platform and their chances of clinical success.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ATNF-ATNF&v=1772530683138 "A chart showing the difference between the consensus forecast and the actual stock price. ATNF (ATNF)")
Analyst consensus forecast for stock prices by market segment - Crypto
180 Life Sciences (ATNF) / ETHZilla is an early-stage biotech company developing drugs to treat inflammation. (The "Crypto" category seems misleading.) This chart shows the overall expectations of analysts for the biotech sector. It reflects whether experts believe speculative R&D projects will succeed.
Analysts' consensus forecast for the overall market share price
ETHZilla Corporation (ATNF) is a micro-cap company that, as its name suggests, is attempting to capitalize on hyped-up topics like cryptocurrency. It's a highly speculative asset. This chart shows the overall risk appetite in the market. It reflects how willing investors are to invest in the most volatile and opaque "stories."
AKIMA index of the company, segment and market as a whole
AKiMA Company Index ATNF
180 Life Sciences (ATNF) is a biotech R&D company focused on inflammation. Their R&D pipeline (led by the godfather of anti-TNF) targets fibrosis (Dupuytren's disease) and pain. This chart is a pure indicator of faith in their R&D. It doesn't reflect revenue, but rather a speculative valuation of their (very risky) pipeline and their clinical trial data.
AKIMA Market Segment Index - Crypto
ETHZilla Corporation (180 Life Sciences) is, contrary to its ticker symbol, a biotech company founded by industry veterans. They focus on treating fibrosis and inflammation (Dupuytren's disease). This chart compares their composite index to the sector, showing how their approach compares to the crypto industry, which their ticker symbol mistakenly categorizes them as.
The AKIM Index for the overall market
ETHZilla (180 Life Sciences) is a biotech company focused on inflammatory diseases (fibrosis, pain). It has changed its ticker symbol to ATNF. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this speculative microcap story compares to overall economic trends.
